peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Financial documents

Shareholders

Shareholders

Top 10 shareholders as of December 31, 2023.

 NameNumber of sharesOwnership in pct
 Redmile Group, LLC9,653,21418.3%
 Nexttobe AB2,155,3794.1%
 Jeansson, Theodor2,100,0003.7%
 Olausson, Thomas1,917,0003.6%
 Försäkrings AB Avanza Pension1,765,5063.4%
 Fjärde AP-Fonden (AP 4)1,700,0003.2%
 Tredje AP-Fonden (AP 3)1,389,6502.6%
 Max Mitteregger Kapitalförvaltning AB725,0001.4%
 VOB & T Trading AB644,8001.2%
 BWG Invest SARL600,0001.1%
 Other30,021,24757.0%
 Total52,671,796100.0%

Source: S&P Global compiled and processed data from various sources, including Euroclear, Morningstar, Factset and the Swedish Financial Supervisory Authority (Finansinspektionen).

Hansa Biopharma had approximately 20,000 shareholders as of December 31, 2023.

Classification of ownership as per June 30, 2023

Region

57%
21%
22%

Category

59%
27%
9%
5%